Preserved C-peptide in survivors of COVID-19: post-hoc analysis
Author(s)
Type
Journal Article
Date Issued
2022-03
Date Acceptance
2021-11-29
Citation
Diabetes, Obesity and Metabolism: a journal of pharmacology and therapeutics, 2022, 24 (3), pp.570-574
ISSN
1462-8902
Publisher
Wiley
Start Page
570
End Page
574
Journal / Book Title
Diabetes, Obesity and Metabolism: a journal of pharmacology and therapeutics
Volume
24
Issue
3
Copyright Statement
© 2021 The Authors. Diabetes, Obesity and Metabolism published by John Wiley & Sons Ltd.
This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
License URL
Sponsor
National Institute for Health Research
Medical Research Council
Medical Research Council (MRC)
Identifier
https://dom-pubs.onlinelibrary.wiley.com/doi/10.1111/dom.14608
Grant Number
CS-2018-18-ST2-002
MR/T006242/1
MR/T006242/1
Subjects
Science & Technology
Life Sciences & Biomedicine
Endocrinology & Metabolism
TYPE-1 DIABETES-MELLITUS
ASSOCIATION
INFECTION
C-Peptide
COVID-19
Humans
SARS-CoV-2
Survivors
Humans
C-Peptide
Survivors
COVID-19
SARS-CoV-2
1103 Clinical Sciences
Endocrinology & Metabolism
Publication Status
Published
Date Publish Online
2021-11-30